ALSO NOTED: Allergan to close Irish plant, lay off 300; FDA grants quick review to Velcade use;

> Allergan plans to shutter its manufacturing facility in Arklow, Ireland, by mid-2009, leaving 300 without jobs; the plant makes breast implants. Another Irish facility in County Mayo won't be affected; that plant makes the wrinkle-reducer Botox. Report

> The FDA will fast-track review of Millennium Pharmaceuticals' application to expand the use of its cancer med Velcade to newly diagnosed multiple myeloma. Release

> Too many similar drug names equals many more medical errors, some of them deadly, according to a new report from Pharmacopeia. Report

> Iroko Pharmaceuticals bought the non-U.S. rights to Merck's Aggrastat heart drug. Report

> Carl Icahn says that Biogen Idec essentially ran a sham when it put itself up for auction recently, putting in place barriers that warded off serious bidding by Big Pharma companies. Now he's made a bid to place three new directors on Biogen's board, and is hoping to gain control of the company. Report

> The rapid move toward offshoring drug trials has sparked controversies over the ethics involved in some of these studies. Report

> A team of scientists at the University of Buffalo have spun off a company to commercialize a new chemical synthesis that they say can far more efficiently create and manufacture new compounds. Report

> Is synthetic biotechnology the next big thing in drug R&D? Report

And Finally... Even as the demand for new antibiotics grows, new research programs to advance fresh therapies have been drying up fast. Report

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.